BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32819845)

  • 1. Comparing prognostic factors of Glut-1 expression and maximum standardized uptake value by FDG-PET in patients with resectable pancreatic cancer.
    Takahashi M; Nojima H; Kuboki S; Horikoshi T; Yokota T; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Ohtsuka M
    Pancreatology; 2020 Sep; 20(6):1205-1212. PubMed ID: 32819845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
    Kitasato Y; Yasunaga M; Okuda K; Kinoshita H; Tanaka H; Okabe Y; Kawahara A; Kage M; Kaida H; Ishibashi M
    Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
    Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
    Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of preoperative [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma.
    Ariake K; Motoi F; Shimomura H; Mizuma M; Maeda S; Terao C; Tatewaki Y; Ohtsuka H; Fukase K; Masuda K; Hayashi H; Takadate T; Naitoh T; Taki Y; Unno M
    J Gastrointest Surg; 2018 Feb; 22(2):279-287. PubMed ID: 29119533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer.
    Pergolini I; Crippa S; Salgarello M; Belfiori G; Partelli S; Ruffo G; Pucci A; Zamboni G; Falconi M
    Dig Liver Dis; 2018 Jan; 50(1):84-90. PubMed ID: 29017830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative carbohydrate antigen 19-9 and standard uptake value of positron emission tomography-computed tomography as prognostic markers in patients with pancreatic ductal adenocarcinoma.
    Moon D; Kim H; Han Y; Byun Y; Choi Y; Kang J; Kwon W; Jang JY
    J Hepatobiliary Pancreat Sci; 2022 Oct; 29(10):1133-1141. PubMed ID: 33063453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma.
    Gu X; Zhou R; Li C; Liu R; Zhao Z; Gao Y; Xu Y
    BMC Cancer; 2019 May; 19(1):456. PubMed ID: 31092213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection.
    Xu HX; Chen T; Wang WQ; Wu CT; Liu C; Long J; Xu J; Zhang YJ; Chen RH; Liu L; Yu XJ
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1093-102. PubMed ID: 24522797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
    Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
    Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
    Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
    Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of
    Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
    Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Su W; Zhao S; Chen Y; Zuo C; Cui B; Wang M; Ren F
    Abdom Radiol (NY); 2020 Mar; 45(3):743-749. PubMed ID: 31907569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of
    Zheng H; Cui Y; Li X; Du B; Li Y
    Clin Lung Cancer; 2019 Nov; 20(6):420-428. PubMed ID: 31300363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.
    Chong JU; Hwang HK; Lee JH; Yun M; Kang CM; Lee WJ
    PLoS One; 2017; 12(2):e0172606. PubMed ID: 28235029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
    Davis-Yadley AH; Abbott AM; Pimiento JM; Chen DT; Malafa MP
    Pancreas; 2016 Aug; 45(7):974-9. PubMed ID: 26692443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved prognostic value of standardized uptake value corrected for blood glucose level in pancreatic cancer using F-18 FDG PET.
    Lee SM; Kim TS; Lee JW; Kim SK; Park SJ; Han SS
    Clin Nucl Med; 2011 May; 36(5):331-6. PubMed ID: 21467846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.